Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Quinones as antimycobacterial agents.

Thuyanh Tran1, Ekta Saheba, Ariana V Arcerio

  • 1Department of Biological Sciences, The University of Texas at El Paso, 500 West University Drive, El Paso, TX 79968, USA.

Bioorganic & Medicinal Chemistry
|September 1, 2004
PubMed
Summary

New biocides targeting Mycobacterium tuberculosis and other hardy mycobacteria were identified. A quinone compound showed bactericidal activity, offering a potential solution for drug-resistant infections.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Circadian clock and cancer.

Military Medical Research·2026
Same author

A rare case of gastric ascariasis.

ASM case reports·2026
Same author

Antimicrobial activity of sulbactam-durlobactam against <i>Acinetobacter baumannii-calcoaceticus</i> complex strains causing non-respiratory and non-bloodstream infections from the United States (2023-2025).

Microbiology spectrum·2026
Same author

Public Health.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Public Health.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Small worms big discoveries: <i>Galleria mellonella</i> as a model for <i>Campylobacter jejuni</i> infection.

Frontiers in cellular and infection microbiology·2025

Area of Science:

  • Microbiology
  • Drug Discovery
  • Infectious Diseases

Background:

  • Mycobacterium tuberculosis poses a significant global health risk, causing millions of deaths annually.
  • Nontuberculous mycobacteria (NTM), such as Mycobacterium avium, are increasing pathogens in immunocompromised individuals.
  • Mycobacteria exhibit natural resistance to disinfectants, and antibiotic development has stalled since the 1970s, necessitating novel antimicrobial agents.

Purpose of the Study:

  • To screen a small aromatic compound library for antimycobacterial activity.
  • To identify novel biocides effective against various mycobacterial species.
  • To explore potential new therapeutic strategies against mycobacterial infections.

Main Methods:

  • Screening of a small aromatic compound library against four mycobacterial species (M. tuberculosis complex, slow-growing NTM, rapid-growing NTM).

Related Experiment Videos

  • Determination of minimal inhibitory concentrations (MICs) for active compounds.
  • Evaluation of a fluorescent reporter assay for predicting inhibitory activity.

    • Main Results:

    • Several active compounds were identified, with minimal inhibitory concentrations as low as 12.5 microg/mL.
    • A quinone was identified as the primary active component responsible for the observed activity.
    • The compounds demonstrated primarily bactericidal activity, suggesting a unique mechanism of action.
    • A fluorescent reporter assay using M. smegmatis expressing gfp was found to be unreliable for predicting inhibitory activity.

    Conclusions:

    • Novel quinone-based compounds show significant potential as antimycobacterial biocides.
    • These compounds may offer a new therapeutic avenue against drug-resistant mycobacteria and other resilient pathogens.
    • Further research is warranted to explore their utility as soluble biocides for clinical applications.